Revvity Schedules Q2 2026 Earnings Call Amid Revenue Growth
Event summary
- Revvity will release its second quarter 2026 financial results on August 4, 2026.
- The earnings call will be hosted by CEO Prahlad Singh and CFO Max Krakowiak at 7:30 a.m. ET.
- Revvity reported $2.9 billion in revenue for 2025 with approximately 11,000 employees.
The big picture
Revvity's earnings call comes as the company continues to position itself as a leader in health science solutions, focusing on areas like multi-omics technologies and biomarker identification. With $2.9 billion in revenue for 2025, the results will be closely watched by investors to gauge its ability to maintain growth amid increasing competition in the healthcare technology sector.
What we're watching
- Revenue Trajectory
- How Revvity's Q2 2026 results will reflect its growth strategy in health science solutions.
- Operational Efficiency
- Whether the company can sustain its operational scale with 11,000 employees.
- Market Positioning
- The pace at which Revvity expands its presence in translational multi-omics and biomarker identification.
Related topics